REGN vs THRM · P/E 14, rev $14.34B vs P/E 49, rev $1.46B
Regeneron Pharmaceuticals Inc (REGN) versus Gentherm Inc (THRM) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Gentherm Inc (THRM) is a auto parts company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported THRM revenue for 2024-12-31 was $1.46B. Net income was $64.9M. Revenue was down 0.9% from 2023-12-31 to 2024-12-31. THRM currently screens at market cap $1.10B and trailing P/E 49.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. THRM currently screens at market cap $1.10B and trailing P/E 49.1.
Not investment advice. Open the REGN and THRM stock pages for the full models.
Not investment advice.